me too.
fallen, your inbox is full.
I just have issues with people who promote bad science :) [QUOTE=GlenW][QUOTE=pastmember/Bren]The stims are all from the Meth group even our Dr. said it to my wife. This is why it must be monitored more. How can speed slow a person down?[/QUOTE]
Ok - let me clear this one up. Meth is in the SAME group as the other amphetamines. That ALSO include pseudo-ephedrine - you know the stuff you take for a stuffy nose? Lots of medications are molecularly similar - but you can't lump them together. Methamphetamines are targeted specifically at areas of the brain to make a person high. That's its only purpose. They make Crystal methamphetamines usually by taking cold medications with pseudo-ephedrine and changing a couple of chemical bonds in it. But cold meds don't get you high - meth does.
Cocaine is chemically similar to novocaine, procaine, and other surgical anasthetics. Change a couple bonds and you go from getting high to being able to have your teeth drilled.
Wood alcohol is a couple of hydrocarbon bonds away from grain alcohol. Which would you drink and which would you use to clean a cut?
Lots of organic chemicals are similar. But when we start yelling one is the other - we are lying either to this group - or ourselves which is infinitely unforgivable.
[/QUOTE]I love it, You Talkin to Me,
You tell 'em.
retalin is speed,,,that is what my doctor told me,,,,it is a stimulate,,,if you r not adha,,,you could not sit still,,,but for people and kids that have adhd and take it it calms them,,,like as if they were taking a valium,,,,,, It's not You Talk Into Me?[QUOTE=pastmember/Bren]The stims are all from the Meth group even our Dr. said it to my wife. This is why it must be monitored more. How can speed slow a person down?[/QUOTE]
Ok - let me clear this one up. Meth is in the SAME group as the other amphetamines. That ALSO include pseudo-ephedrine - you know the stuff you take for a stuffy nose? Lots of medications are molecularly similar - but you can't lump them together. Methamphetamines are targeted specifically at areas of the brain to make a person high. That's its only purpose. They make Crystal methamphetamines usually by taking cold medications with pseudo-ephedrine and changing a couple of chemical bonds in it. But cold meds don't get you high - meth does.
Cocaine is chemically similar to novocaine, procaine, and other surgical anasthetics. Change a couple bonds and you go from getting high to being able to have your teeth drilled.
Wood alcohol is a couple of hydrocarbon bonds away from grain alcohol. Which would you drink and which would you use to clean a cut?
Lots of organic chemicals are similar. But when we start yelling one is the other - we are lying either to this group - or ourselves which is infinitely unforgivable.
Slows down ADHDers. Gives them more to think about on one subject before they go to the next. "davidornado,,,tell me is it fun to try and make fun of peopel on site,,,i have seen different posts from you,,,makes me think you forgot to take your mds,,,,why the reason of it any way.........................."
lol,,,cute bugzappers
Thats like saying that ritalin is crystal meth using your argument.
I TEND TO BELIEVE
YOU TALKIN TO ME.
Speed is amphetamine, or methamphetamine.I ALSO TEND TO BE
BELIEVE
FALLEN
Cool man, does that make me a crystal meth junkie??
WOO HOO!!! Rock on with my BAD self!

That's ok chuckles - I'm sure Davidornado is readying a full color diarama of the whole thing as we speak LOL!!! He's good for that kind of thing - many days I have to scroll for what seems forever through what seems to be one of my old biology textbooks!
Sounds like you've taken your share of advanced bio, or like the rest of us ADHDers you soak the stuff up involuntary like stale beer in a bar sponge.
The whole thing confuses people because the concepts are alien to anything outside the neurons, ganglions and axions of the brain. It's scary to people - and like most scared public the naysayers get all jittery and begin their anti-med dance to appease the gods of no reason "fire BAD AAARRRRR!! fire BAD!!!"
It's like and unlike a computer I like to confuse the cats with that one. Like a computer in that the brain cells store information in bio-electrical energy between the cells like a binary bit in a RAM chip. Unlike computers in that it's far from binary - you can have a little, a lot and many flavors that would make baskin robins blush in shame. The chemicals like norepinephrine (adrenaline folks), dopamine (think "awakenings" and "michael J. fox") amongst a cavalcade of stars do things like sustain a cells workings, make communications faster/slower, change the rate of transfer, etc. We're all still learning about it so it's new stuff even to the eggheads in charge of the labs.
What we do know is that these amphetamines work differently in the range of disordered and ordered brains that take it. Meth is so different from the rest in that it permanently changes the chemistry to make the user dependent on it within as short as 2 dosages taken in short order. That's a spicy meat a ball!!! Methylphenidate and Dexedrine (sulphate and salts) don't do that no matter what balanced and curus might tell you from their info.
Ritalin and dex (I'm shorthanding as the pro/con sides know the names) are given in such small doses and in chemically stable bases that they are intended to make sure they don't change the chemistry in such a way. To become even psychologically dependent (there's a difference - the naysayers just say dependent but that's outright deception no matter what they make my quotes show next) there needs to be a larger than prescribed amount for a longer than normal duration. Short story short - you don't get hooked on these meds unless that's what you wanted to do in the first place. I don't remember the pamphlet for either showing how to crush the meds and snort them - any more than I remember them saying blame them if the user sells them to some unprescribed junkie that inevitably will die from them (and the naysayers will add that to the tally they keep).
If you take a large dose of Tylenol you kill the liver. A medically allowable dose - you remove fevers, alleve pain and suffering. Don't kill the manufacturer because some parent gives the kid a tylenol (yes I know Ryes syndrome so don't come at me people), then forgets, then gives another 20 minutes later. Most meds that cause damage to people are because of 2 things: the user abuses the meds by either overdosing on them, or taking them in a fashion not prescribed (i.e. with other meds, injecting/snorting pills, etc.) OR the user is not being monitored by a qualified medical professional when instructed to do so.
A child has a heart attack while taking Ritalin. For weeks the child complained of chest pain - did the parent go back to the MD with this complaint right away - or did they wait and ask around to see if this is normal? Is the med at fault if the parent either ignores symptoms of a possible side-effect or never looked into the documentation and took measures to check child for any possible problems?
The terrible potential (though still rare) side effects of these meds are now documented. It's not like at when they discovered them where the children showed signs of problems and the MDs went to the documents and found nothing - so waited to see what happened. They know what to expect in 99 percent of the population's variations of affects. A child gets hives - the MD takes the meds away ASAP and applies antihistamines. A child gets chest pains - MD again removes meds and checks child on EKG and supplies heart aiding care and delves deeper into the situation. If every child was watched the way they are supposed to - the meds would have a 99.9999 percent survival rate. It's good now - but can always be better.
Get mad at neglegent docs. Get mad when parents aren't either informed or interested in their child beyond getting them quiet again. don't punish the meds - they do what they are told to.
GlenW38646.4708449074 Oops. Mailbox empty now.
Ritalin forces the brain to release more dopamine while amphetamines prevent dopamines from being re-used but the effect is virtually the same.
[QUOTE=foggyguy]Ritalin forces the brain to release more dopamine while amphetamines prevent dopamines from being re-used but the effect is virtually the same.
[/QUOTE]
Big difference though: Ritalin when used as DIRECTED has no or little euphoric effect - it works subtly on the mind with the least side effects. Cocaine however - when used as directed is specifically designed to cause euphoria and a feeling of false well-being. BIG difference. It's only when Ritalin is abused by snorting or used in higher than recommended dosages that the affects become similar.
Same with comparing it to meth (damn big stretch). You have to take ADHD meds with amphetamines at much higher than normal dosages to get anywhere near the same affect.
[QUOTE=chjones]just wanted to put that out there. seeing as everyone apparently has it in for cocaine in such a big way.[/QUOTE]
I don't. If it weren't so prohibitevely expensive nor proscriptively illegal, I'd have it in for cocaine in such a big way!
These last few posts indicate the fractile nature of dialectible English.
e.g. Smartass
in Canadian is meant to indicate one thing, whilst in the lingua franca of California it is perceived to engender quite a colloquial, or colonial, as the case may be, origin.
I suppose they drive different, there, also...
I have it on the highest (no pun intended, but certainly appreciated hehe) authority that snorting Ritalin is less effective than oral ingestion, as nasal membranes are less permeable to the a.i. than the gastrointestinal tract.
Therefore, could snorting Ritalin be held as abusive use?
While carefully, but cautiously, considering the snuffling, sniffling, snortee is in possession of prescriptive permission allowing aforesaid's acquisition, custody, care, and consumption.
[QUOTE=GlenW]Cocaine however - when used as directed [/QUOTE]
Hey! I'd like to meet your prescriptor...
[QUOTE=Davidornado][QUOTE=GlenW]Cocaine however - when used as directed [/QUOTE]
Hey! I'd like to meet your prescriptor...
[/QUOTE]
Smartass
You know whut I meant - coke used as intended - snorted or smoked in crack form - or injected is intended for the sole purpose of euphoria and stimulation. No other purpose - unless you count the weirdos who use it to torture themselves by applying it to their sex organs in order to numb feeling - I heard it called a "nummer" - when applied by someone.. uh.. orally.
[QUOTE=Davidornado]These last few posts indicate the fractile nature of dialectible English.
e.g. Smartass
in Canadian is meant to indicate one thing, whilst in the lingua franca of California it is perceived to engender quite a colloquial, or colonial, as the case may be, origin.
I suppose they drive different, there, also...
[/QUOTE]
How very interesting - thanks! Learn somethin' new every day!
Yes - we drive different than in Caleeforniuh.. we don't have automatic weapons so when mad at other drivers - we are forced to wave at them and write a heated letter to our local member of parliament at how unhappy we are!
Woo-hoo! Great Idea, Glen!!!
I'm gonna try that next time!
The RED Wave!!!
Wait a sec, that might get ME shot...
Where's my body ardor?
[QUOTE=Davidornado]I have it on the highest (no pun intended, but certainly appreciated hehe) authority that snorting Ritalin is less effective than oral ingestion, as nasal membranes are less permeable to the a.i. than the gastrointestinal tract.
Therefore, could snorting Ritalin be held as abusive use?
While carefully, but cautiously, considering the snuffling, sniffling, snortee is in possession of prescriptive permission allowing aforesaid's acquisition, custody, care, and consumption.
[/QUOTE]
ADD Exists.
ADHD is a REALITY.
atheiADHDism is BOGUS.
BALANCED society accepts truth.
Nonsense is often spouted by the unbalanced.
Ritalin, ADDerall, Strattera, and their a.i.'s are effective
frontline
medicinal

hey not here!!



[quote=brookelea]
International Consensus Statement on ADHD
January
2002
We, the
undersigned consortium of international scientists, are deeply concerned
about the periodic inaccurate portrayal of attention deficit hyperactivity
disorder (ADHD) in media reports. This is a disorder with which we are all very
familiar and toward which many of us have dedicated scientific studies if not
entire careers. We fear that inaccurate stories rendering ADHD as myth,
fraud, or benign condition may cause thousands of sufferers not to seek
treatment for their disorder. It also leaves the public with a general
sense that this disorder is not valid or real or consists of a rather trivial
affliction.
We have created this consensus statement on ADHD as a reference on the status
of the scientific findings concerning this disorder, its validity, and its
adverse impact on the lives of those diagnosed with the disorder as of this
writing (January 2002).
Occasional coverage of the disorder casts the story in the form of a sporting
event with evenly matched competitors. The views of a handful of non-expert
doctors that ADHD does not exist are contrasted against mainstream scientific
views that it does, as if both views had equal merit. Such attempts at balance
give the public the impression that there is substantial scientific
disagreement over whether ADHD is a real medical condition. In fact, there is
no such disagreement --at least no more so than there is over whether smoking
causes cancer, for example, or whether a virus causes HIV/AIDS.
The U.S. Surgeon General, the American Medical Association (AMA), the American
Psychiatric Association, the American Academy of Child and
Adolescent Psychiatry (AACAP), the American Psychological Association, and the American Academy of Paediatrics (AAP), among others, all
recognize ADHD as a valid disorder. While some of these organizations have
issued guidelines for evaluation and management of the disorder for their
membership, this is the first consensus statement issued by an independent
consortium of leading scientists concerning the status of the disorder. Among
scientists who have devoted years, if not entire careers, to the study of this
disorder there is no controversy regarding its existence.
ADHD
and Science
We cannot over emphasize the point that, as a matter of science, the notion
that ADHD does not exist is simply wrong. All of the major medical associations
and government health agencies recognize ADHD as a genuine disorder because the
scientific evidence indicating it is so is overwhelming.
Various approaches have been used to establish whether a condition rises to the
level of a valid medical or psychiatric disorder. A very useful one stipulates
that there must be scientifically established evidence that those suffering the
condition have a serious deficiency in or failure of a physical or
psychological mechanism that is universal to humans. That is, all humans
normally would be expected, regardless of culture, to have developed that
mental ability.
And there must be equally incontrovertible scientific evidence that this
serious deficiency leads to harm to the individual. Harm is established through
evidence of increased mortality, morbidity, or impairment in the major life
activities required of one's developmental stage in life. Major life activities
are those domains of functioning such as education, social relationships,
family functioning, independence and self-sufficiency, and occupational
functioning that all humans of that developmental level are expected to
perform.
As attested to by the numerous scientists signing this document, there is no
question among the world's leading clinical researchers that ADHD involves a
serious deficiency in a set of psychological abilities and that these
deficiencies pose serious harm to most individuals possessing the disorder.
Current evidence indicates that deficits in behavioral inhibition and sustained
attention are central to this disorder -- facts demonstrated through hundreds
of scientific studies. And there is no doubt that ADHD leads to impairments in
major life activities, including social relations, education, family
functioning, occupational functioning, self-sufficiency, and adherence to
social rules, norms, and laws. Evidence also indicates that those with ADHD are
more prone to physical injury and accidental poisonings. This is why no
professional medical, psychological, or scientific organization doubts the
existence of ADHD as a legitimate disorder.
The central psychological deficits in those with ADHD have now been linked
through numerous studies using various scientific methods to several specific
brain regions (the frontal lobe, its connections to the basal ganglia, and
their relationship to the central aspects of the cerebellum). Most neurological
studies find that as a group those with ADHD have less brain electrical
activity and show less reactivity to stimulation in one or more of these
regions. And neuro-imaging studies of groups of those with ADHD also
demonstrate relatively smaller areas of brain matter and less metabolic
activity of this brain matter than is the case in control groups used in these
studies.
These same psychological deficits in inhibition and attention have been found
in numerous studies of identical and fraternal twins conducted across various
countries (US, Great Britain, Norway, Australia, etc.) to be
primarily inherited. The genetic contribution to these traits is routinely
found to be among the highest for any psychiatric disorder (70-95% of trait
variation in the population), nearly approaching the genetic contribution to
human height. One gene has recently been reliably demonstrated to be associated
with this disorder and the search for more is underway by more than 12
different scientific teams worldwide at this time.
Numerous studies of twins demonstrate that family environment makes no
significant separate contribution to these traits. This is not to say that the
home environment, parental management abilities, stressful life events, or
deviant peer relationships are unimportant or have no influence on individuals
having this disorder, as they certainly do. Genetic tendencies are expressed in
interaction with the environment. Also, those having ADHD often have other
associated disorders and problems, some of which are clearly related to their
social environments. But it is to say that the underlying psychological
deficits that comprise ADHD itself are not solely or primarily the result of
these environmental factors.
This is why leading international scientists, such as the signers below,
recognize the mounting evidence of neurological and genetic contributions to
this disorder. This evidence, coupled with countless studies on the harm posed
by the disorder and hundreds of studies on the effectiveness of medication,
buttresses the need in many, though by no means all, cases for management of
the disorder with multiple therapies. These include medication combined with
educational, family, and other social accommodations. This is in striking
contrast to the wholly unscientific views of some social critics in periodic
media accounts that ADHD constitutes a fraud, that medicating those afflicted
is questionable if not reprehensible, and that any behavior problems associated
with ADHD are merely the result of problems in the home, excessive viewing of
TV or playing of video games, diet, lack of love and attention, or
teacher/school intolerance.
ADHD is not a benign disorder. For those it afflicts, ADHD can cause
devastating problems. Follow-up studies of clinical samples suggest that
sufferers are far more likely than normal people to drop out of school
(32-40%), to rarely complete college (5-10%), to have few or no friends
(50-70%), to under perform at work (70-80%), to engage in antisocial activities
(40-50%), and to use tobacco or illicit drugs more than normal. Moreover,
children growing up with ADHD are more likely to experience teen pregnancy
(40%) and sexually transmitted diseases (16%), to speed excessively and have
multiple car accidents, to experience depression (20-30%) and personality
disorders (18-25%) as adults, and in hundreds of other ways mismanage and
endanger their lives.
Yet despite these serious consequences, studies indicate that less than half of
those with the disorder are receiving treatment. The media can help
substantially to improve these circumstances. It can do so by portraying ADHD
and the science about it as accurately and responsibly as possible while not
purveying the propaganda of some social critics and fringe doctors whose
political agenda would have you and the public believe there is no real
disorder here. To publish stories that ADHD is a fictitious disorder or merely
a conflict between today's Huckleberry Finns and their caregivers is tantamount
to declaring the earth flat, the laws of gravity debatable, and the periodic
table in chemistry a fraud. ADHD should be depicted in the media as
realistically and accurately as it is depicted in science -- as a valid
disorder having varied and substantial adverse impact on those who may suffer
from it through no fault of their own or their parents and teachers.
Sincerely,
Russell A. Barkley, Ph.D.
Professor
Depts. Of Psychiatry and Neurology
University of Massachusetts Medical School
55 Lake Avenue North
Worcester, MA 01655
Edwin H. Cook, Jr., M.D.
Professor
Departments of Psychiatry and Pediatrics
University of Chicago
5841 S. Maryland
Ave.
Chicago, IL
Mina Dulcan, M.D.
Professor
Department of Child and Adolescent Psychiatry
2300 Children's Plaza #10
Children's Memorial Hospital
Chicago, IL 60614
Susan Campbell, Ph.D.
Professor
Department of Psychology
4015 O'Hara Street
University of Pittsburgh
Pittsburgh, PA 15260
Margot Prior, Ph.D.
Professor
Department of Psychology
Royal Children's Hospital
Parkville, 3052 VIC
Australia
Marc Atkins, Ph.D.
Associate Professor
University of Illinois at Chicago
Institute for Juvenile Research
Department of Psychiatry
840 South Wood Street, Suite 130
Chicago, IL 60612-7347
Christopher Gillberg, M.D.
Professor
Department of Child and Adolescent Psychiatry
University of Gothenburg
Gothenburg, Sweden Mary Solanto-Gardner, Ph.D.
Associate Professor
Division of Child and Adolescent Psychiatry
The Mt. Sinai Medical Center
One Gustave L. Levy Place
New York, NY 10029-6574
Jeffrey Halperin, Ph.D.
Professor,
Department of Psychology
Queens College, CUNY
65-30 Kissena Ave.
Flushing, NY 11367
Jose J. Bauermeister, Ph.D.
Professor,
Department of Psychology
University of Puerto Rico
San Juan, PR 00927
Steven R. Pliszka, M.D.
Associate Professor and Chief
Division of Child and Adolescent Psychiatry
University of Texas Health Sciences Center
7703 Floyd Curl Drive
San Antonio, TX 78229-3900
Mark A. Stein, Ph.D.
Chair of Psychology
Children's National Medical Center and
Professor of Psychiatry & Pediatrics
George Washington Univ. Med. School
111 Michigan Ave. NW
Washington, DC 20010
John S. Werry, M.D.
Professor Emeritus
Department of Psychiatry
University of Auckland
Auckland, New Zealand
Joseph Sergeant, Ph.D.
Chair of Clinical Neuropsychology
Free University
Van der Boecharst Straat 1
De Boelenlaan 1109
1018 BT Amsterdam
The Netherlands
Ronald T. Brown, Ph.D.
Associate Dean, College of Health Professions
Professor of Pediatrics
Medical University of South Carolina
19 Hagood Avenue
P. O. Box 250822
Charleston, SC 29425
Alan Zametkin, M.D.
Child Psychiatrist
Kensington, MD
Arthur D. Anastopoulos, Ph.D.
Professor, Co-Director of Clinical Training
Department of Psychology
University of North Carolina at Greensboro
P. O. Box 26164
Greensboro, NC 27402-6164
James J. McGough, M.D.
Associate Professor of Clinical Psychiatry
UCLA School of Medicine
760 Westwood Plaza
Los Angeles, CA 90024
George J. DuPaul, Ph.D.
Professor of School Psychology
Lehigh University
111 Research Drive, Hilltop Campus
Bethlehem, PA 18015 Stephen V. Faraone, Ph.D.
Associate Professor of Psychology
Harvard University
750 Washington St., Suite 255
South Easton, MA 02375
Florence Levy, M.D.
Associate Professor
School of Psychiatry
University of New South Wales
Avoca Clinic
Joynton Avenue
Zetland, NSW, 2017, Australia
Mariellen Fischer, Ph.D.
Professor,
Department of Neurology
Medical College of Wisconsin
9200 W. Wisconsin Avenue
Milwaukee, WI 53226
Joseph Biederman, M.D.
Professor and Chief
Joint Program in Pediatric Psychopharmacology
Massachusetts General Hospital and
Harvard Medical School
15 Parkman St., WACC725
Boston, MA 02114
Cynthia Hartung, Ph.D.
Assistant
Professor
Oklahoma State University
215 North Murray
Stillwater, OK 74078
Stephen Houghton, Ph.D.
Professor of Psychology
Director,
Centre for Attention & Related Disorders
The University of Western Australia
Perth, Australia
Gabrielle Carlson, M.D.
Professor and Director,
Division of Child and Adolescent Psychiatry
State University of New
York at Stony
Brook, Putnam Hall
Stony Brook, NY 11794
Charlotte Johnston, Ph.D.
Professor
Department of Psychology
University of British Columbia
2136 West Mall
Vancouver, BC, Canada V6T 1Z4 Thomas Spencer, M.D.
Associate Professor and Assistant Director,
Pediatric Psychopharmacology
Harvard Medical School and
Massachusetts General Hospital
15 Parkman St., WACC725
Boston, MA 02114
Thomas Joiner, Ph.D.
The Bright-Burton Professor of Psychology
Florida State University
Tallahassee, FL 32306-1270
Rosemary Tannock, Ph.D.
Professor of Psychiatry,
Brain and Behavior Research
Hospital for Sick Children
55 University Avenue
Toronto, Ontario, Canada M5G 1X8
Adele Diamond, Ph.D.
Professor of Psychiatry
Director, Center for Developmental Cognitive Neuroscience
University of Massachusetts Medical School
Shriver Center
Trapelo Rd.
Waltham, MA
Carol Whalen, Ph.D.
Professor
Department of Psychology and Social Behavior
University of California at Irvine
3340 Social Ecology II
Irvine, CA 02215
Stephen P. Hinshaw, Ph.D.
Professor,
Department of Psychology #1650
University of California at Berkeley
3210 Tolman Hall
Berkeley, CA 94720-1650
Herbert Quay, Ph.D.
Professor Emeritus
University of Miami
2525 Gulf of Mexico Drive, #5C
Long Boat Key, FL 34228
John Piacentini, Ph.D.
Associate Professor
Department of Psychiatry
UCLA Neuropsychiatric Institute
760 Westwood Plaza
Los Angeles, CA 90024-1759
Philip Firestone, Ph.D.
Professor
Departments of Psychology & Psychiatry
University of Ottawa
120 University Priv.
Ottawa, Canada K1N 6N5
Salvatore Mannuzza, M.D.
Research Professor of Psychiatry
New York University School of Medicine
550 First Avenue
New York, NY 10016
Keith McBurnett, Ph.D.
Associate Professor
Department of Psychiatry
University of California at San Francisco
Children's Center at Langley Porter
401 Parnassus Avenue, Box 0984
San Francisco, CA 94143
Linda Pfiffner, Ph.D.
Associate Professor
Department of Psychiatry
University of California at San Francisco
Children's Center at Langley Porter
401 Parnassus Avenue, Box 0984
San Francisco, CA 94143
Oscar Bukstein, M.D.
Associate Professor
Department of Psychiatry
Western Psychiatric Institute and Clinic
3811 O'Hara
Street
Pittsburgh, PA 15213
Ken C. Winters, Ph.D.
Associate Professor
Director, Center for Adolescent
Substance Abuse Research
Department of Psychiatry
University of Minnesota
F282/2A West, 2450
Riverside Ave.
Minneapolis, MN 55454
Michelle DeKlyen, Ph.D.
Office of Population Research
Princeton University
286 Wallace
Princeton, NJ 08544
Lily Hechtman M.D. F.R.C.P.
Professor of Psychiatry and Pediatrics,
Director of Research,
Division of Child Psychiatry,
McGill University, and
Montreal Childrens Hospital.
4018 St.
Catherine St.
West.,
Montreal, Quebec, Canada. H3Z-1P2
Caryn Carlson, Ph.D.
Professor
Department of Psychology
University of Texas at Austin
Mezes 330
Austin, TX 78712
Donald R. Lynam, Ph.D.
Associate Professor
University of Kentucky
Department of Psychology
125 Kastle Hall
Lexington, KY 40506-0044
Lisa L. Weyandt, Ph.D.
Professor, Dept. of Psychology
Central Washington University
400 East 8th Avenue
Ellensburg, WA 98926-7575
Michael Gordon, Ph.D.
Professor of Psychiatry
Director,
Child & Adolescent Psychiatric Services, & Director,
ADHD Program
SUNY Upstate Medical University
750 East Adams Street
Syracuse, NY 13210
Patrick H. Tolan Ph.D.
Director, Institute for Juvenile Research
Professor, Department of Psychiatry
University of Illinois at Chicago
840 S. Wood Street
Chicago, IL 60612
Jan Loney, Ph.D.
Professor Emeritus
State University of New
York at Stony
Brook
Lodge Associates (Box 9)
Mayslick, KY 41055
Harold S. Koplewicz, M.D.
Arnold and Debbie Simon
Professor of Child and Adolescent Psychiatry
and Director of the NYU Child Study Center
Richard Milich, Ph.D.
Professor of Psychology
Department of Psychology
University of Kentucky
Lexington, KY 40506-0044
Laurence Greenhill, M.D.
Professor of Clinical Psychiatry
Columbia University
Director, Research Unit on Pediatric Psychopharmacology
New York State Psychiatric Institute
1051 Riverside Drive
New York, NY 10032
Eric J. Mash, Ph.D.
Professor
Department of Psychology
University of Calgary
2500 University
Drive N.W.
Calgary, Alberta T2N 1N4
Russell Schachar, M.D.
Professor of Psychiatry
Hospital for Sick Children
555
University Avenue
Toronto, Ontario
Canada M5G 1X8
Eric Taylor
Professor of Psychiatry
Institute of Psychiatry
London, England
Betsy Hoza, Ph.D.
Associate Professor
Department of Psychology, #1364
Purdue University
West Lafayette, IN 47907-1364
Mark. D. Rapport, Ph.D.
Professor and Director of Clinical Training
Department of Psychology
P.O. Box
161390
University of
Central Florida
Orlando, Florida 32816-1390
Bruce Pennington, Ph.D.
Professor
Department of Psychology
University of Denver
2155 South Race Street
Denver, CO 80208
Anita Thapar MB BCh, MRCPsych, PhD
Professor,
Child and Adolescent Psychiatry Section
Dept of Psychological Medicine
University of Wales College of Medicine
Heath Park, Cardiff
CF14 4XN United Kingdom
Ann Teeter, Ed.D.
Director of Training, School Psychology
University of Wisconsin - Milwaukee
Milwaukee, WI 53201
Stephen Shapiro, Ph.D.
Department of Psychology
Auburn University
226 Thach
Auburn, AL 36849-5214
Avi Sadeh, D.Sc
Director, Clinical Child Psychology Graduate Program
Director, The Laboratory for Children's Sleep Disorders
Department of Psychology
Tel-Aviv University
Ramat Aviv, Tel Aviv 69978
ISRAEL
Bennett L. Leventhal, M.D.
Irving B. Harris Professor of Child and Adolescent Psychiatry
Director, Child & Adolescent Psychiatry
Vice Chairman, Dept. of Psychiatry
The University of Chicago
5841 S. Maryland Ave.
Chicago, IL 60637
Hector R. Bird, M.D.
Professor of Clinical Psychiatry
Columbia University
College of Physicians and Surgeons
1051
Riverside Drive
(Unit 78)
New York, NY 10032
Carl E. Paternite, Ph.D.
Professor of Psychology
Miami University
Oxford, OH 45056
Mary A. Fristad, PhD, ABPP
Professor, Psychiatry & Psychology
Director, Research & Psychological Services
Division of Child & Adolescent Psychiatry
The Ohio State University
1670 Upham Drive Suite 460G
Columbus, OH 43210-1250
Brooke Molina, Ph.D.
Assistant Professor of Psychiatry and Psychology
Western Psychiatric Institute and Clinic
University of Pittsburgh School of Medicine
3811 O'Hara Street
Pittsburgh, PA 15213
Sheila Eyberg, PhD, ABPP
Professor of Clinical &Health Psychology
Box 100165
1600 SW Archer Blvd.
University of Florida
Gainesville, FL 32610
Rob McGee,PhD
Associate Professor,
Department of Preventive & Social Medicine,
University of Otago Medical School,
Box 913 Dunedin,
New Zealand.
Terri L. Shelton, Ph.D.
Director
Center for the Study of Social Issues
University of North Carolina - Greensboro
Greensboro, NC 27402
Steven W. Evans, Ph.D.
Associate Professor of Psychology
MSC 1902
James Madison University
Harrisonburg, VA 22807
Sandra K. Loo, Ph.D.
Research Psychologist
University of California, Los
Angeles
Neuropsychiatric Institute
760 Westwood Plaza, Rm 47-406
Los Angeles, CA 90024
William Pelham, Jr., Ph.D.
Professor of Psychology
Center Children and Families
State University of New York at Buffalo
318 Diefendorf Hall
3435 Main Street, Building 20
Buffalo, NY 14214
J. Bart Hodgens, Ph.D.
Clinical Assistant Professor
of Psychology and Pediatrics
Civitan International Research Center
University of Alabama at Birmingham
Birmingham, AL 35914
Terje Sagvolden, Ph.D.
Professor
Department of Physiology
University of Oslo
N-0316 Oslo, Norway
Thomas E. Brown, Ph.D.
Asst. Professor
Dept. of Psychiatry
Yale University School of Medicine
New Haven, CT
Daniel F. Connor, M.D.
Associate Professor
Department of Psychiatry
University of Massachusetts Medical School
55 Lake Avenue North
Worcester, MA 01655
Daniel A. Waschbusch, Ph.D.
Assistant Professor of Psychology
Director, Child Behaviour Program
Department of Psychology
Dalhousie University
Halifax, NS B3H 4R1 CANADA
Kevin R. Murphy, Ph.D.
Assistant Professor
Dept. of Psychiatry
University of Massachusetts Medical School
55 Lake Avenue North
Worcester, MA 01655
Michael Aman, Ph.D.
Professor of Psychology and Psychiatry
The Nisonger Center
Ohio State University
1581 Dodd Drive
Columbus, Ohio, U.S.A.
Blythe Corbett, Ph.D.
M.I.N.D. Institute
University of California, Davis
4860 Y Street, Suite 3020
Sacramento, CA 95817
Deborah L. Anderson, Ph.D.
Assistant
Professor
Department Pediatrics
Medical University of South
Carolina
Charleston, SC 29425
Lawrence Lewandowski, Ph.D.
Meredith Professor of Teaching Excellence
Department of Psychology
Syracuse University
Syracuse, NY
Howard Abikoff, Ph.D. Pevaroff Cohn
Professor of Child and Adolescent Psychiatry
NYU School of Medicine
Director of Research
NYU Child Study Center
550 First Avenue
New York, NY 10016
[/quote]
Sorry, no resemblence, in chemical structure, nor pharmacology, of methylphenidate, ecgonine methyl ester benzoate, or the latter's metabolite, benzoylecgonine.
Their only similarity may be an effect on serotonin reuptake through inhibition of the serotonin transport system. However, this is only postulated at this time. There are three other areas where cocaine is significantly different: it's influence on norepinephrine reuptake, serotonin reuptake, and sodium channelling. Any combination of the four different modes of action has a logarithmic increase in the complexity of activity in the cerebral environment.
That ecgonine methyl ester benzoate's metabolite, benzoylecgonine, would be similar in structure or activity to methylphenidate is also untenable.
Methylphenidate
methylaphenyl-2-piperidylacetate
MPH is a dopamine reuptake inhibitor, which means that it increases the level of the dopamine neurotransmitter in the brain by partially blocking the transporters that remove it from the synapses.

Cocaine
ecgonine methyl ester benzoate
3-benzoyloxy-8-methyl-8-azabicyclo [3.2.1]octane-4-carboxylic acid methyl ester
Cocaine is a potent blocker of the dopamine transporter (DAT) and a less potent blocker of the norepinephrine transporter (NET) and serotonin transporter (SERT). Cocaine also blocks sodium channels, thereby interfering with the propagation of action potentials; thus, like lidocaine and novocaine, it acts as a local anesthetic.
Benzoylecgonine
3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylic acid
Benzoylecgonine is the major metabolite of cocaine. It is formed by hydrolysis of cocaine in the liver, catalysed by carboxylesterases.